HomeCompareADKCF vs PFE

ADKCF vs PFE: Dividend Comparison 2026

ADKCF yields 3.14% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $25.1K in total portfolio value· pulled ahead in Year 9
10 years
ADKCF
ADKCF
● Live price
3.14%
Share price
$22.50
Annual div
$0.71
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$384.18
Full ADKCF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — ADKCF vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodADKCFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ADKCF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ADKCF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADKCF
Annual income on $10K today (after 15% tax)
$266.79/yr
After 10yr DRIP, annual income (after tax)
$326.55/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $21,993.35/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADKCF + PFE for your $10,000?

ADKCF: 50%PFE: 50%
100% PFE50/50100% ADKCF
Portfolio after 10yr
$37.0K
Annual income
$13,321.45/yr
Blended yield
35.99%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

ADKCF
No analyst data
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADKCF buys
0
PFE buys
0
No recent congressional trades found for ADKCF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricADKCFPFE
Forward yield3.14%6.13%
Annual dividend / share$0.71$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$24.5K$49.6K
Annual income after 10y$384.18$26,258.71
Total dividends collected$3.5K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ADKCF vs PFE ($10,000, DRIP)

YearADKCF PortfolioADKCF Income/yrPFE PortfolioPFE Income/yrGap
1$11,014$313.87$9,153$693.39+$1.9KADKCF
2$12,108$323.07$8,593$849.25+$3.5KADKCF
3$13,287$331.93$8,336$1,066.78+$5.0KADKCF
4$14,558$340.43$8,437$1,384.80+$6.1KADKCF
5$15,926$348.59$9,013$1,875.40+$6.9KADKCF
6$17,397$356.39$10,306$2,680.72+$7.1KADKCF
7$18,978$363.84$12,820$4,101.38+$6.2KADKCF
8$20,678$370.95$17,673$6,826.70+$3.0KADKCF
9← crossover$22,503$377.73$27,543$12,591.86$5.0KPFE
10$24,462$384.18$49,560$26,258.71$25.1KPFE

ADKCF vs PFE: Complete Analysis 2026

ADKCFStock

Adeka Corporation engages in chemicals, food products, and life science businesses. The company offers polymer additives, such as antioxidants, UV absorbers/hindered amine light stabilizers, nucleating agents/clarifiers, metal deactivators/additives for filled polymers, flame retardants, epoxy type stabilizers/lubricants/processability improvers/water dispersion type stabilizers; plasticizers/PVC stabilizers; and light/thermal curing materials, initiators, polymerizable materials, resist materials, thermal paper materials, semiconductor materials, and circuit materials. Its chemical products also comprise functional polymers, including water borne, epoxy, low chlorine epoxy, and urethane resins; surface specialties, such as general-purpose and functional surfactants, functional cosmetic ingredients, lubricant additives, and base materials for lubricants; propylene glycol, peroxygen chemicals, metal soaps, and inorganic chemicals; and inducing joint fillers and sealing materials, as well as civil engineering and construction materials. The company offers its chemical products to electronics and IT, plastics and rubber, personal care, industrial, liquid crystal display, automotive, and building and construction industries, as well as paints, coatings, and adhesives industries. In addition, it provides food products, such as margarines, shortening products, oils and fats for chocolate, frying oil, whipping cream, concentrated milk type creams, fillings, frozen pie doughs, mayonnaise and dressing, functional foods, and others under the RISU BRAND name. Further, the company engages in various businesses, such as plant facility design; construction and construction management; and facility maintenance, logistics, warehousing, vehicles leasing, real estate, and insurance agency. The company was formerly known as Asahi Denka Co., Ltd. and changed its name to Adeka Corporation in May 2006. The company was incorporated in 1917 and is headquartered in Tokyo, Japan.

Full ADKCF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this ADKCF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADKCF vs SCHDADKCF vs JEPIADKCF vs OADKCF vs KOADKCF vs MAINADKCF vs JNJADKCF vs MRKADKCF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.